At a glance
- Originator Nonindustrial source; Novo Nordisk
- Class Analgesics
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Pain in Denmark (Unknown route)
- 02 Sep 1998 No-Development-Reported for Pain in Italy (Unknown route)
- 16 Jul 1996 New profile